SCHEMBL4147235

SCHEMBL4147235

c1cnc(C(Nc2nccc(Nc3cc(CCc4ccco4)n[nH]3)n2)c2cnco2)nc1

nearest known ligand 0.36

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 7/20 0.36
FGFR1 P11362 3/20 0.36
KDR P35968 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4158014 0.88 IGF1R (0.39) IGF1RFGFR1KDR
SCHEMBL4557094 0.85 IGF1R (0.36) IGF1RFGFR1KDR
SCHEMBL4160491 0.83 IGF1R (0.41) IGF1RFGFR1KDR
SCHEMBL3942011 0.75 IGF1R (0.40) IGF1RFGFR1KDR
SCHEMBL4159933 0.75 IGF1R (0.39) IGF1RFGFR1KDR
SCHEMBL4161747 0.73 NTRK1 (0.35) IGF1RFGFR1KDR
SCHEMBL5096819 0.72 IGF1R (0.49) IGF1RFGFR1KDR
SCHEMBL4167900 0.72 IGF1R (0.46) IGF1RFGFR1KDR
SCHEMBL5103415 0.72 IGF1R (0.62) IGF1RFGFR1KDR
SCHEMBL4169882 0.71 HTR7 (0.39) IGF1RFGFR1KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2044063-A1 PYRIMIDINE DERIVATIVES USEFUL IN THE TREATMENT OF CANCER Astra Zeneca AB (SE) 2009-04-08 EP disclosed
WO-2008001070-A1 PYRIMIDINE DERIVATIVES USEFUL IN THE TREATMENT OF CANCER ASTRAZENECA AB (SE) 2008-01-03 WO disclosed